| | | | | | | | | Sponsored | | Respond to changes in demand and seasonality during respiratory season and beyond. The Panther Fusion® system provides a streamlined workflow with a flexible syndromic testing menu so that your lab is prepared to deliver results for every patient, every time. Does your solution fit your workflows, reimbursement structures, and clinical demand? |
|
|
| | |
| |
| | |
|
|
| | | | | | This Q&A offers a deeper dive into CAP's “Utility of Molecular Testing in the Diagnostic Workup of Difficult-to-Classify Tumors,” breaking down where molecular testing could aid with the diagnosis of difficult tumors, how AI can be used to support clinical decision making, and next steps for labs. |
|
|
| | With recently cleared appropriate molecular tests for both saliva and urine samples, health providers and laboratory personnel can ensure that fewer cCMV cases slip through the cracks and that more babies get timely treatment to minimize effects of cCMV later in life. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Mass trauma situations require rapid decision-making and flawless execution. Is your facility using the latest preparedness strategies? Join our upcoming webinar, led by a published expert in disaster medicine. See registration page for full program details. Alba Bioscience is an approved provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. |
|
|
| | |
| |
| | |
|
|
| | | | | | NG Biotech and Hardy Diagnostics have secured FDA Breakthrough Device Designations for two rapid assays, NG-TEST Candida auris and NG-TEST Acineto-5, enhancing early detection of critical pathogens linked to antimicrobial resistance. These tests provide results within 15 minutes. |
|
|
|
| |
| | |
|
|
| | | | | | This is a call for industry professionals to contribute to MLO's research on Lab Management Best Practices by completing a short, anonymous survey before March 6, 2026. The findings will be featured in the May 2026 publication, providing valuable insights. |
|
|
|
| |
| | |
|
|
| | | | | | Merck and Mayo Clinic have entered a strategic partnership where they will utilize artificial intelligence (AI) for drug research and development. Details of the partnership are reported in a press release. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|